UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 38

Sortiert nach

The promise of personalized medicine for hidradenitis suppurativa

British journal of dermatology (1951), 2023-01, Vol.188 (1), p.3-3

Okun, Martin M

2023

Link zum Volltext

Verfügbarkeit prüfen

Patients’ willingness to accept adverse event and cost tradeoffs from oral nicotinamide for reduced risk of non-melanoma skin cancer

The Journal of dermatological treatment, 2023-12, Vol.34 (1), p.2247105-2247105

2023

Link zum Volltext

Verfügbarkeit prüfen

Achieving Hidradenitis Suppurativa Response Score is Associated with Significant Improvement in Clinical and Patient-reported Outcomes: Post Hoc Analysis of Pooled Data From PIONEER I and II

Acta dermato-venereologica, 2018-11, Vol.98 (10), p.932-937

2018

Link zum Volltext

Verfügbarkeit prüfen

Adalimumab treatment optimization for psoriasis: Results of a long-term phase 2/3 Japanese study

Journal of dermatology, 2015-11, Vol.42 (11), p.1042-1052

2015

Link zum Volltext

Verfügbarkeit prüfen

Long-term adalimumab efficacy in patients with moderate-to-severe hidradenitis suppurativa/acne inversa: 3-year results of a phase 3 open-label extension study

Journal of the American Academy of Dermatology, 2019-01, Vol.80 (1), p.60-69.e2

2019

Link zum Volltext

Verfügbarkeit prüfen

Hidradenitis Suppurativa: Diagnosis and Management in the Emergency Department

The Journal of emergency medicine, 2022-11, Vol.63 (5), p.636-644

2022

Link zum Volltext

Verfügbarkeit prüfen

Adalimumab for nail psoriasis: Efficacy and safety from the first 26 weeks of a phase 3, randomized, placebo-controlled trial

Journal of the American Academy of Dermatology, 2018-01, Vol.78 (1), p.90-99.e1

2018

Link zum Volltext

Verfügbarkeit prüfen

What causes hidradenitis suppurativa ?—15 years after

Experimental dermatology, 2020-12, Vol.29 (12), p.1154-1170

2020

Link zum Volltext

Verfügbarkeit prüfen

Uncovering burden disparity: A comparative analysis of the impact of moderate-to-severe psoriasis and hidradenitis suppurativa

Journal of the American Academy of Dermatology, 2017-12, Vol.77 (6), p.1038-1046

2017

Link zum Volltext

Verfügbarkeit prüfen

Psoriasis Area and Severity Index: Nuts and bolts of measuring disease severity in psoriasis

Clinics in dermatology, 2008-11, Vol.26 (6), p.653-656

Okun, Martin M., PhD

2008

Link zum Volltext

Verfügbarkeit prüfen

Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: Double-blind, randomized controlled trial and open-label extension study

Journal of the American Academy of Dermatology, 2006-10, Vol.55 (4), p.598-606

2006

Link zum Volltext

Verfügbarkeit prüfen

Validation of the Physician’s Global Assessment of Fingernail Psoriasis by Rheumatologists Treating Psoriatic Arthritis

Value in health, 2022-09, Vol.25 (9), p.1582-1589

2022

Link zum Volltext

Verfügbarkeit prüfen

Outcome Measures for the Evaluation of Treatment Response in Hidradenitis Suppurativa for Clinical Practice: A HiSTORIC Consensus Statement

JAMA dermatology (Chicago, Ill.), 2023-11, Vol.159 (11), p.1258

2023

Link zum Volltext

Verfügbarkeit prüfen

No Evidence that Variations in Ambient Solar Ultraviolet Radiation and Psoriasis Severity are Associated

Journal of psoriasis and psoriatic arthritis, 2022-04, Vol.7 (2), p.67-70

2022

Link zum Volltext

Verfügbarkeit prüfen

L1 Interaction Domains of Papillomavirus L2 Necessary for Viral Genome Encapsidation

Journal of Virology, 2001-05, Vol.75 (9), p.4332-4342

2001

Link zum Volltext

Verfügbarkeit prüfen

Psoriasis Area and Severity Index : Nuts and bolts of measuring disease severity in psoriasis: Combating Aging Skin: Part II

Clinics in dermatology, 2008, Vol.26 (6), p.653-656

OKUN, Martin M

2008

Link zum Volltext

Verfügbarkeit prüfen

Adalimumab Efficacy in Hidradenitis Suppurativa Patients is Sustained at Least Three Years with Weekly Dosing: Results from a Phase 3 Open-Label Extension Study (PIONEER)

Skin (Milwood, N.Y.), 2017-10, Vol.1, p.s128

2017

Link zum Volltext

Verfügbarkeit prüfen

Adalimumab for Nail Psoriasis: Efficacy and Safety from the Open-Label Extension of a Phase-3, Randomized, Placebo-Controlled Trial

Skin (Milwood, N.Y.), 2017-10, Vol.1, p.s97

2017

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Adalimumab among Patients with Moderate to Severe Psoriasis with Co-Morbidities

American journal of clinical dermatology, 2011-02, Vol.12 (1), p.51

2011

Link zum Volltext

Verfügbarkeit prüfen

Biologic and Systemic Agents in Hidradenitis Suppurativa

Biologic and Systemic Agents in Dermatology, 2018, p.365-376

Okun, Martin M.

2018

Link zum Volltext

Verfügbarkeit prüfen

Translocation of preproinsulin across the endoplasmic reticulum membrane. The relationship between nascent polypeptide size and extent of signal recognition particle-mediated inhibition of protein synthesis

The Journal of biological chemistry, 1992-06, Vol.267 (16), p.11476-11482

1992

Link zum Volltext

Verfügbarkeit prüfen

Truncations of a secretory protein define minimum lengths required for binding to signal recognition particle and translocation across the endoplasmic reticulum membrane

The Journal of biological chemistry, 1990-05, Vol.265 (13), p.7478-7484

1990

Link zum Volltext

Verfügbarkeit prüfen

Proposed recommendations for diagnosing and managing individuals with glutaric aciduria type I: second revision

Journal of inherited metabolic disease, 2017, Vol.40 (1), p.75-101

2017

Link zum Volltext

Verfügbarkeit prüfen

Deep brain stimulation in the internal capsule and nucleus accumbens region: responses observed during active and sham programming

Journal of neurology, neurosurgery and psychiatry, 2007-03, Vol.78 (3), p.310-314

2007

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 38

Suche als RSS-Feed

Aktive Filter

PublikationsformBücher

ThemaTreatment Outcome

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(37)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(29)
Life Sciences & Biomedicine
(28)
Humans
(22)
Dermatology
(13)
Female
(12)
Male
(10)
Adult
(8)
Middle Aged
(7)
Animals
(6)
Biological And Medical Sciences
(6)
Hidradenitis Suppurativa
(6)
Adalimumab
(5)
Biochemistry & Molecular Biology
(5)
Severity Of Illness Index
(5)
Medical Sciences
(4)
Aged
(3)
Double-Blind Method
(3)
Fundamental And Applied Biological Sciences. Psychology
(3)
Genetics & Heredity
(3)
Hidradenitis Suppurativa - Diagnosis
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The promise of personalized medicine for hidradenitis suppurativa

Patients’ willingness to accept adverse event and cost tradeoffs from oral nicotinamide for reduced risk of non-melanoma skin cancer

Achieving Hidradenitis Suppurativa Response Score is Associated with Significant Improvement in Clinical and Patient-reported Outcomes: Post Hoc Analysis of Pooled Data From PIONEER I and II

Adalimumab treatment optimization for psoriasis: Results of a long-term phase 2/3 Japanese study

Long-term adalimumab efficacy in patients with moderate-to-severe hidradenitis suppurativa/acne inversa: 3-year results of a phase 3 open-label extension study

Hidradenitis Suppurativa: Diagnosis and Management in the Emergency Department

Adalimumab for nail psoriasis: Efficacy and safety from the first 26 weeks of a phase 3, randomized, placebo-controlled trial

What causes hidradenitis suppurativa ?—15 years after

Uncovering burden disparity: A comparative analysis of the impact of moderate-to-severe psoriasis and hidradenitis suppurativa

Psoriasis Area and Severity Index: Nuts and bolts of measuring disease severity in psoriasis

Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: Double-blind, randomized controlled trial and open-label extension study

Validation of the Physician’s Global Assessment of Fingernail Psoriasis by Rheumatologists Treating Psoriatic Arthritis

Outcome Measures for the Evaluation of Treatment Response in Hidradenitis Suppurativa for Clinical Practice: A HiSTORIC Consensus Statement

No Evidence that Variations in Ambient Solar Ultraviolet Radiation and Psoriasis Severity are Associated

L1 Interaction Domains of Papillomavirus L2 Necessary for Viral Genome Encapsidation

Psoriasis Area and Severity Index : Nuts and bolts of measuring disease severity in psoriasis: Combating Aging Skin: Part II

Adalimumab Efficacy in Hidradenitis Suppurativa Patients is Sustained at Least Three Years with Weekly Dosing: Results from a Phase 3 Open-Label Extension Study (PIONEER)

Adalimumab for Nail Psoriasis: Efficacy and Safety from the Open-Label Extension of a Phase-3, Randomized, Placebo-Controlled Trial

Efficacy and Safety of Adalimumab among Patients with Moderate to Severe Psoriasis with Co-Morbidities

Biologic and Systemic Agents in Hidradenitis Suppurativa

Translocation of preproinsulin across the endoplasmic reticulum membrane. The relationship between nascent polypeptide size and extent of signal recognition particle-mediated inhibition of protein synthesis

Truncations of a secretory protein define minimum lengths required for binding to signal recognition particle and translocation across the endoplasmic reticulum membrane

Proposed recommendations for diagnosing and managing individuals with glutaric aciduria type I: second revision

Recommendations for diagnosing and managing individuals with glutaric aciduria type 1: Third revision

Deep brain stimulation in the internal capsule and nucleus accumbens region: responses observed during active and sham programming

Aktive Filter

Suchergebnisse filtern